Rezatapopt Achieves Antitumor Activity Across Subgroups in TP53 Y220C–Positive Ovarian Cancer - Targeted Oncology
Rezatapopt Achieves Antitumor Activity Across Subgroups in TP53 Y220C–Positive Ovarian Cancer Targeted Oncology
Ovarian Cancer News
Rethinking ovarian cancer III: the past decade and future directions - Nature
Rethinking ovarian cancer III: the past decade and future directions Nature
Genetic testing leads to early diagnosis of ovarian cancer: Sally’s story - Roswell Park Comprehensive Cancer Center
Genetic testing leads to early diagnosis of ovarian cancer: Sally’s story Roswell Park Comprehensive Cancer Center
Radon Risk Is Real—And It May Include Ovarian Cancer - Pharmacy Times
Radon Risk Is Real—And It May Include Ovarian Cancer Pharmacy Times
Radon and Ovarian cancer risk - KSDK
Radon and Ovarian cancer risk KSDK
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape
SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape
She refused to slow down: How one runner took on cancer and now the Boston Marathon - Gulf Coast News and Weather
She refused to slow down: How one runner took on cancer and now the Boston Marathon Gulf Coast News and Weather
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer - CancerNetwork
REGN5668 Combo Yields Preliminary Activity in Recurrent Ovarian/Endometrial Cancer CancerNetwork
Zentalis Pharmaceuticals Presents Promising Preclinical Data on Azenosertib in Triple-Negative Breast Cancer and Insights on Cyclin E1-Positive Ovarian Cancer at AACR 2026 - Quiver Quantitative
Zentalis Pharmaceuticals Presents Promising Preclinical Data on Azenosertib in Triple-Negative Breast Cancer and Insights on Cyclin E1-Positive Ovarian Cancer at AACR 2026 Quiver Quantitative
SAGA Diagnostics to Present New Pathlight MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026 - Business Wire
SAGA Diagnostics to Present New Pathlight MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026 Business Wire
Sandy Sprint 5K returns to Philly Navy Yard, marks 25 years of ovarian cancer fight - FOX 29 Philadelphia
Sandy Sprint 5K returns to Philly Navy Yard, marks 25 years of ovarian cancer fight FOX 29 Philadelphia
AbbVie Ovarian Cancer Data And Pain Deal Extend Long Term Story - Yahoo Finance
AbbVie Ovarian Cancer Data And Pain Deal Extend Long Term Story Yahoo Finance
FDA Grants Fast Track Designation to CTIM-76 for Platinum-Resistant Ovarian Cancer - OncLive
FDA Grants Fast Track Designation to CTIM-76 for Platinum-Resistant Ovarian Cancer OncLive
Study shows residential radon exposure linked to higher ovarian cancer risk in postmenopausal women - WKYC
Study shows residential radon exposure linked to higher ovarian cancer risk in postmenopausal women WKYC
25-Year-Old's Pain Dismissed as Acid Reflux, Later Diagnosed as Ovarian Cancer (Exclusive) - People.com
25-Year-Old's Pain Dismissed as Acid Reflux, Later Diagnosed as Ovarian Cancer (Exclusive) People.com
FDA Lifts Clinical Hold on Lorigerlimab Trial in Ovarian Cancer - Targeted Oncology
FDA Lifts Clinical Hold on Lorigerlimab Trial in Ovarian Cancer Targeted Oncology
Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer - Medscape
Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer Medscape
Sofetabart Mipitecan Hits 50% Response Rate in Platinum-Resistant Ovarian Cancer - Targeted Oncology
Sofetabart Mipitecan Hits 50% Response Rate in Platinum-Resistant Ovarian Cancer Targeted Oncology
Nivo-Ipi Breaks Resistance in Rare Ovarian Subtypes - Medscape
Nivo-Ipi Breaks Resistance in Rare Ovarian Subtypes Medscape
Relacorilant Plus Nab-Paclitaxel Significantly Improves OS in Platinum-Resistant Ovarian Cancer - OncLive
Relacorilant Plus Nab-Paclitaxel Significantly Improves OS in Platinum-Resistant Ovarian Cancer OncLive
Combining new drug with chemotherapy extends survival of platinum-resistant ovarian cancer patients in clinical trial - Medical Xpress
Combining new drug with chemotherapy extends survival of platinum-resistant ovarian cancer patients in clinical trial Medical Xpress
In resistant breast cancer mice, Zentalis drug drove 7 of 8 complete responses - Stock Titan
In resistant breast cancer mice, Zentalis drug drove 7 of 8 complete responses Stock Titan
Cannabis derivatives could provide new ovarian cancer treatments - Frontiers
Cannabis derivatives could provide new ovarian cancer treatments Frontiers
Radon Gas Increases Risk Of Ovarian Cancer, Study Says - U.S. News & World Report
Radon Gas Increases Risk Of Ovarian Cancer, Study Says U.S. News & World Report
FDA Grants Fast Track Designation to CTIM-76 for Platinum-Resistant Ovarian Cancer - Targeted Oncology
FDA Grants Fast Track Designation to CTIM-76 for Platinum-Resistant Ovarian Cancer Targeted Oncology
LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference - Yahoo Finance
LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference Yahoo Finance
New research links radon exposure to ovarian cancer - WXYZ Channel 7
New research links radon exposure to ovarian cancer WXYZ Channel 7
Relacorilant/Nab-Paclitaxel Offers New Option in Platinum-Resistant Ovarian Cancer - CancerNetwork
Relacorilant/Nab-Paclitaxel Offers New Option in Platinum-Resistant Ovarian Cancer CancerNetwork
'How I knew I had ovarian cancer’: Survivors and caregiver discuss symptoms - UT MD Anderson
'How I knew I had ovarian cancer’: Survivors and caregiver discuss symptoms UT MD Anderson
New PARP Inhibitor Resistance Mechanisms Found in Ovarian Cancer - Bioengineer.org
New PARP Inhibitor Resistance Mechanisms Found in Ovarian Cancer Bioengineer.org
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment - UC San Diego Today
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment UC San Diego Today
Lung cancer drug offers a surprising new treatment against ovarian cancer - Mayo Clinic News Network
Lung cancer drug offers a surprising new treatment against ovarian cancer Mayo Clinic News Network
Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference - GlobeNewswire
Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference GlobeNewswire
Radon: Common Household Gas, Tied to Ovarian Cancer Risk - HealthDay
Radon: Common Household Gas, Tied to Ovarian Cancer Risk HealthDay
Zentalis (Nasdaq: ZNTL) unveils azenosertib TNBC and Cyclin E1 ovarian cancer data at AACR 2026 - Stock Titan
Zentalis (Nasdaq: ZNTL) unveils azenosertib TNBC and Cyclin E1 ovarian cancer data at AACR 2026 Stock Titan
‘Wait Time Paradox’ Flags Difficulties in Ovarian Cancer Diagnosis - Inside Precision Medicine
‘Wait Time Paradox’ Flags Difficulties in Ovarian Cancer Diagnosis Inside Precision Medicine
Tip Sheet: Johns Hopkins Kimmel Cancer Center at AACR Annual Meeting | Newswise - Newswise
Tip Sheet: Johns Hopkins Kimmel Cancer Center at AACR Annual Meeting | Newswise Newswise
Ovarian cancer trial expands after 40% disease control in 20 patients - Stock Titan
Ovarian cancer trial expands after 40% disease control in 20 patients Stock Titan
A Common Household Chemical Has Just Been Linked with a Surprising Type of Cancer - The Healthy @Reader's Digest
A Common Household Chemical Has Just Been Linked with a Surprising Type of Cancer The Healthy @Reader's Digest